MedPath

TRI-CIRA LO 21

TRI-CIRA LO 21

Approved
DIN Number

02401967

Drug Class

Human

Market Date

Jun 9, 2014

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02401967
AIG Number0636783003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB09 NORGESTIMATE AND ETHINYLESTRADIOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

ETHINYL ESTRADIOLActive
Strength: 0.025 MG
Monograph: ETHINYL ESTRADIOL
NORGESTIMATEActive
Strength: 0.18 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.215 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.25 MG
Monograph: NORGESTIMATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.